Bone tendon junction injury is hard to cure because of its special anatomical structure, and the treatment applied for bone-tendon junction injury cannot result in the perfect vascular regeneration and restoration of the fibrocartilage zone. In this article, we aim to explore the effect of caveolin-1 as a slow-release material on bonetendon junction healing. Seventy-two New Zealand rabbits were randomly selected and assigned into the experimental, sham-operated and control groups (n = 24).
| INTRODUCTION
The bone-tendon junction is where the tendon attaches to the bone, and it is composed of soft tendon tissues and hard ones.
1,2 Unfortunately, the injury of the bone-tendon junction is increased and commonly found in trauma and sports exercise, caused by muscle loading, which often occurs in different ligaments, including Achilles tendon, anterior cruciate ligament, rotator cuff and patellar tendon. 3 Hence, the research on bone-tendon junction healing is of clinical value for preventing injuries and improving treatment. 4 Nevertheless, bonetendon junction healing is at a slower rate compared with bone-bone healing and tendon-tendon healing. 5 Among the possible factors, a poorly recovered fibrocartilage zone and short transition distance between the hard and soft tissues are the major ones contributing to inferior bone-tendon junction healing. 6 Moreover, numerous fibrous tissues occur between bone and tendon in the process of bonetendon junction reconstruction, which is difficult to differentiate into fibrocartilage thus weakening the mechanical capacity of the bonetendon junction healing interface. 7 At present, many treatment regimens have been investigated on bone-tendon junction healing, comprising noninvasive techniques or physical therapies using lowintensity pulsed ultrasound, extracorporeal shock-wave therapy as well as electrical stimulation. 6 As the restoration of the transition zone in the bone-tendon junction healing is of critical importance after an injury to maintain the mechanical properties of the bone-tendon junction, 8 it is essential to find a kind of potential material which may be possessed with such ability. Caveolin-1, a small 22-kDa protein of caveolae membranes in endothelial and fibroblasts, 9, 10 is able to function in lipid traffic, membrane traffic, and signal transduction. 11 Caveolin-1 function loss has been reported in stromal cells of multiple organs that lead to benign stromal lesions are responsible for aberrant epithelium growth and differentiation, and caveolin-1 expression in fibroblasts can remodel the extracellular matrix to regulate cell shape. 12 We therefore hypothesized that caveolin-1 could be developed as a slow-release material to affect bone-tendon junction healing. The present study was designed to evaluate and compare the histological changes and mechanical properties of tissue healing in surgically created tendon bone-tendon junction injuries in a rabbit model in response to caveolin-1 as a slow-release material to provide a new light on bonetendon junction healing by using biological materials (Supporting Information Figure S1 ).
| MATERIALS AND METHODS

| Animal grouping and model establishment
Seventy-two New Zealand rabbits (female: 35; male: 37; age:
18 weeks, weight: 2.5~3.2 kg) provided by the Second Affiliated
Hospital of Army Medical University were randomly selected and assigned into the control group (n = 24), the experimental group (n = 24), and the sham-operated group (n = 24). Patellar patellectomy was performed at the left lower limb of rabbits. All the animal experiment and the animal welfare were in accordance with the Guide for the Care and Use of Laboratory Animal by International Committees.
In the control and the experimental groups, the patellar patellectomy was carried out on the left lower limb of rabbits to establish the rabbit model. The rabbits were anesthetized with 3% sodium pentobarbital. The left hind legs were shaved and disinfected with alcohol, and a sterile towel was placed under the legs. In the experimental group, the patella was exposed through an anterolateral skin incision and the length of the patella was measured. A transverse osteotomy was performed at the distal 1/3 of the patella. The distal 1/3 of the patella and a few patella tendons were removed. Two tunnels were drilled longitudinally through the proximal 2/3 of the patella with a diameter of 0.8 mm. Then the bunnel tendon suture was applied to the patellar tendon, by which the release material was sutured to the proximal patella. After suturing, the wounds were rinsed and the incision was closed. The left lower limbs were immobilized using a leg cast at the position of 3/4 length, while allowing as much as 90 knee flexion. The rabbits in the control group were not planted caveolin-1 slow-release material. On the third day after surgery, the rabbits were intramuscularly injected with 40 × 10 4 U penicillin, and the incision and blood transport were observed every other day. After surgery, rabbits in different groups were housed in different cages and fed with food and water. After 4 weeks, the leg casts were removed and the rabbits were allowed to move freely within their cages. In the sham-operated group, the anesthesia process was the same, and following patella exposure, no osteotomy was performed but sutured as other groups.
| Preparation of caveolin-1 chitosan microsphere
The classical ion cross-linking method was applied with modifications.
A certain amount of chitosan (CTS) was taken and dissolved in 1% acetic acid, and adjusted to pH 5.4 with NaOH solution. 
| Drug loading and entrapment efficiency of caveolin-1 CTS microspheres
The average particle size and particle size distribution of caveolin-1 CTS microspheres were determined by using a laser diffraction particle size analyzer (Winner2308A, Winner Particle, Ji'nan, China). In this experiment, the enzyme-linked immunosorbent assay (ELISA) kit with high sensitivity was used to detect the amount of residual caveolin-1 in the supernatant after centrifugation, thereby determining the drug loading rate and entrapment efficiency rate of caveolin-1 CTS microspheres.
According to the ELISA kit instructions, the absorbance (A) 450 value was examined. The concentration of caveolin-1 in the sample was calculated based on the standard equation of the standard curve, and the total amount of caveolin-1 in the centrifugation and supernatant was calculated. The drug loading rate = m1/m2*100%, the entrapment efficiency rate = m1/m3*100%, the m1 was quality of caveolin-1 protein in the microsphere, the m2 was quality of microsphere, and the m3 was quality of caveolin-1. The experiment was repeated three times.
| Release of caveolin-1 by caveolin-1 CTS microspheres in vitro
Three tubes (5 mL) were taken and added with 50 mg CTS microspheres in each tube. Then, 2 mL phosphate buffered saline (PBS, pH 7.4) containing 10 7 U/L of lysozyme was added and shaken fully at 37 C water bath. At the 6th hour, 12th hour, 18th hour, 24th hour, 48th hour and 72nd hour, the concentration of caveolin-1 was determined, and then the observation was carried out every 3 days. The end point of the observation was at the 30th day. The solution was centrifuged at 40256g for 15 min, after which the supernatant was extracted (100 pL each time), and supplemented with 100 pI PBS, and then, the shaking continued. The ELISA kit was used to detect the concentration of caveolin-1, and the mean value was calculated, and the release curve was drawn.
| Sample preparation
Twenty-four rabbits (eight from each group) were executed at the 4th, 8th, and 12th weeks after surgery by an overdose of intravenous pentobarbital, and the quadriceps muscle-patella-patellar tendon (QMPPT) complexes were collected. The specimens were fixed in 4%
neutral buffered formalin for 24 h, decalcified with ethylene diamine tetraacetic acid (EDTA) for 4 weeks, dehydrated using a gradient alcohol, cleared and embedded in paraffin. Tissue sections (about 5 μm)
were cut at the mid-sagittal plane of the QMPPT complexes.
| Histological examination
The rabbits were euthanized at the 4th, 8th, and 12th weeks after surgery by an overdose of intravenous pentobarbital and the QMPPT complexes were harvested. Then the distal patella tendon of the speci- 
| Biomechanical testing
Sampling and preservation: At the 4th, 8th, and 12th weeks after surgery, the QMPPT complexes for mechanical tests were harvested.
Fresh samples were immersed in 9 g/L isotonic saline, sealed in a centrifuge tube, and stored in a − 20 C freezer for mechanical testing. Measurement of the uniaxial tensile strength of the bone-tendon healing complex: QMPPT complexes were fixed, allowing a 10 between the patella and the axis. A preload was performed on the complexes using a biomechanical testing machine, followed by a tensile failure. Qmat 3.6 software (Housfield Company, London, UK) was applied to record the breaking load. The cross-sectional area and breaking load of the healing interfaces were measured to calculate the ultimate tensile strength.
| Statistical analysis
SPSS21.0 statistical software (IBM Corp. Armonk, NY) was used for data analysis. The measurement data were expressed as a mean ± SD.
Analysis of variance was used for comparison in multiple groups, and LSD-t test was used for comparison between two groups The significance level was set at P < 0.05.
| RESULTS
| Particle size distribution, drug loading rate and entrapment efficiency of the caveolin-1 CTS microspheres
The results of laser analysis showed that the particle size distribution of the microspheres was ranged from 58.8 to 955.6 nm, which was mainly concentrated in the range of 145~532.0 nm. The average particle size of the microspheres was 230.3 nm (Figure 1) . The ELISA kits, the more accurate assay than conventional ones, was adopted to determinate the drug loading and entrapment efficiency of caveolin-1 CTS microspheres. The content of caveolin-1 can be inferred by measuring the residual caveolin-1 in the supernatants and centrifugation washings, thus based on which the drug loading and entrapment efficiency were examined. The entrapment efficiency was 66.867 ± 4.575%, and the drug loading rate was 33.437 ± 2.2901 μg/ml, n = 3.
| Release of caveolin-1 in the caveolin-1 CTS microspheres was consistent with the biphasic kinetics
The in vitro release of caveolin-1 in the caveolin-1 CTS microspheres sustained for 30 days, and it was consistent with the biphasic kinetics ( Figure 2 ). The initial phase was a rapid drug release phase with a burst release effect. The cumulative drug release rate within the first 48 h was 45.867 ± 3.787%, and the rate was 65.967 ± 4.392% on the sixth day. Since then, the release was in the slow drug release phase. On the 15th day, the rate reached 80.767 ± 4.801% and on the 30th day, the rate was 90.133 ± 3.564%, n = 3. This indicated that the release of caveolin-1 in the caveolin-1 CTS microspheres was in accordance with the biphasic kinetics. collagen fibers and chondrocyte-like cells were aligned along the longitudinal axis; no clear formation of fibrocartilage transition zone was found but chondrocyte-like cell proliferation and some vague osteotomy interfaces were observed in the control group, while proliferation of fibroblasts still could be found. At the 12th week after surgery, in the experimental group, the osteotomy interfaces were basically integrated, newly born cancellous bones were found on a large scale and chondrocytes were significantly decreased. Cartilage transition zone was well-aligned and collagen fibers were obviously increased. Moreover, cells and collagen fibers were well-aligned along the longitudinal axis. However, in the control group, fibrocartilage transition zone was formed, chondrocytes were obviously increased, well-aligned collagen fibers were found, and no clear boundaries around the osteotomy site were detected (Figure 3 ). At each time point, tissues in the shamoperated group were normal and there was no significant difference in histological results between females and males.
Safranin'O staining results (Figure 4) showed that at the fourth week postoperatively, bone matrix was stained in deep red in the experimental group with comparatively more proliferating fibroblasts and a concentrated staining area could be detected at the bone-tendon junction;
in the control group, the bone matrix was stained lightly and a light red area was found at the junction. At the eighth week after surgery, the matrix staining was decreased in the experimental group, mainly at the site of chondrocyte-like cells aggregation with light staining; in the control group, the bone matrix was gradually stained deeper, and a large section with red-staining of the matrix was found at the bone-tendon interface. At the 12th week after surgery, chondrocyte-like cells at the bone-tendon junction were gradually decreased in the experimental group and their aggregation section presented in a light color; in the control group, the area of red-staining of matrix was obviously decreased compared with that at the eighth week postoperatively, but very little red-staining could still be found. Tissues in the sham-operated group were normal at each time point.
Masson staining results showed that at the fourth week after surgery, the proliferation of fibrous connective tissue of the bone-tendon surface in the experimental group was serious and new bone formation was found, while in the control group, disordered collagen was detected without new bone formation. At the eighth week after surgery, numerous collagen fibers with staggered arrangement were observed, while in the control group, only a small amount of Compared with the control group, the experimental group exhibited significant difference at the 8th week after surgery (P < 0.05), and significant differences were found at the 4th and the 12th weeks after surgery between the two groups (P < 0.05). According to the breaking load results, the breaking load was increased along with time both in the experimental and control groups. Compared with the control group, there were significant differences in regard to breaking load in the experimental group at the 4th and the 12th weeks after surgery (P < 0.05), but no difference was found at the 8th week after surgery between the two groups (P > 0.05). The ultimate tensile strength showed that in the experimental and the control F I G U R E 3 Caveolin-1 slow release material promotes the formation of new bone and fibrocartilage transition zone detected by H&E staining of bone-tendon junction at the 4th, the 8th and the 12th weeks after surgery (×100). Note: A1-A3, the sham-operated group; B1-B3, the control group; C1-C3, the experimental group; A1, B1, and C1, the staining condition at the 4th week after surgery; A2, B2, and C2, the staining condition at the 8th week after surgery; A3, B3, and C3, the staining condition at the 12th week after surgery; the arrows point to new bone with lower density and fibrocartilage transition zone; H&E, hematoxylin & eosin
With the effect of caveolin-1 slow release material, chondrocyte-like cells at the bone-tendon junction were gradually decreased determined by Safranin'O staining (×100) of bone-tendon junction at the 4th, the 8th, and the 12th weeks after surgery. Note: A1-A3, the sham-operated group; B1-B3, the control group; C1-C3, the experimental group; A1, B1, and C1, the staining condition at the 4th week after surgery; A2, B2, and C2, the staining condition at the 8th week after surgery; A3, B3, and C3, the staining condition at the 12th week after surgery groups, the ultimate tensile strength was increased along with time.
At the same time point (at the 4th, 8th and 12th weeks postoperatively), the ultimate tensile strength in the experimental group was higher than that in the control group (P < 0.05). The breaking load and the ultimate tensile strength were higher in the sham-operated group in contrast to the control group at each time point (P < 0.05). The ultimate tensile strength was increased at the fourth and the eighth weeks postoperatively in the experimental group when compared with that in the sham-operated group (P < 0.05). The cross-sectional area of the healing interfaces, breaking load and ultimate tensile strength at the 12th weeks postoperatively showed no significant difference between the experimental and sham-operated groups (Table 1) . Overall, caveolin-1 as a slow-release material enhanced biomechanical properties of QMMPT complex.
| DISCUSSION
Noninvasive techniques, physical therapies, cell therapy and tissue engineering have been discovered for bone-tendon junction healing, of which allogenic scaffold is a possibility. 13, 14 In this study, we investigated the effects of caveolin-1 as a slow-release material promoting bone-tendon junction healing in rabbits in a comparative study.
New Zealand rabbit models of bone-tendon junction injury at left hind legs were successfully established and caveolin-1 was applied as a slow-release material and planted into the experimental group. The results showed that caveolin-1 could produce an accelerating effect on bone-tendon junction healing.
According to the results observed by X-ray, the area of new bone formation at the bone-tendon junction in the experimental group was larger than that in the control group. This result is consistent with other studies reporting that knockdown of caveolin-1, due to the decrease in
Receptor Activator of Nuclear Factor-κ B Ligand (RNAKL), reduced osteoclastogenesis, which is one of the major producers for new bone resorption through reshaping bone and inhibiting pathological bone loss. 15, 16 On the other hand, the general findings from the experimental animals showed no fibrous proliferation in the experimental group but great fibrous proliferation was observed in the control group. Similar result has been revealed that the loss of caveolae protein in alveolar epithelial cells may result in a serious injury to type I pneumocytes in the process of fibrogenesis. 17 As the histological examination showed, there were numerous well-aligned collagen fibers with well-integrated cut surface in the experimental group. Besides, the experimental group also showed the high expression of polysaccharide, mainly represented by repair of fibrocartilage. Indeed, caveolin-1 plays a key role in regulating glucose transport between arm and leg muscles. 18 This structural protein is also able to regulate junction-associated proteins in endothelial and epithelial cells. 19 It might be due to the regulation of glucose transporting ability that a high expression of polysaccharide appeared, possibly partly composed of glucose. And the regulation of endothelial and epithelial cells of caveolin-1 might serve as a promoting factor for well-integrated cut surface and repair of fibrocartilage. After supplementation of the male animal model, histological findings at the incision showed no significant differences between females and males. This result is consistent with previous studies of traumatic femoral head necrosis animal models. 3, 20, 21 In addition, the cross-sectional area, breaking load and ultimate tensile strength of the healing interface were remarkably increased in the experimental group, indicating that caveolin-1 could play an important role in increasing the mechanical properties. It is in conformity with another research finding that mice injected caveolin-1 present enhanced lung mechanics with an obviously increased airway resistance. 22 Actually, caveolin-1 is reported to be capable of reorganizing cholesterol-enriched tight junction membrane microdomains. 23 A study has shown that caveolin-1 maintains low differentiation of osteoblast and promotes healing of bone and tendon. 24 Therefore, we F I G U R E 5 Caveolin-1 slow release material gradually improved the structure of collagen fibers and promoted new bone formation at bone-tendon junction at the 4th, the 8th, the 12th weeks after surgery (×100). Note: A1-A3, the sham-operated group; B1-B3, the control group; C1-C3, the experimental group; A1, B1, and C1, the staining condition at the 4th week after surgery; A2, B2, and C2, the staining condition at the 8th week after surgery; A3, B3, and C3, the staining condition at the 12th week after surgery speculated that during the process of bone-tendon junction healing, a similar reorganization function may generate at the junction, which can provide a possible approach for caveolin-1 to expand the crosssectional area, elevate breaking load and thus increase the ultimate tensile strength of the healing interface of the bone-tendon junction.
In our study, the slow-release material caveolin-1, a kind of scaffolding protein of caveolae, is also shown to have a function in inhibiting inflammation. 25 And it has been reported in the inhibition of some diseases such as head and neck squamous cell carcinoma. 26 Therefore, considering the unique properties of caveolin-1 and the previous findings, the application of caveolin-1 in bone-tendon junction J healing may be possessed with a similar feasibility to that in other diseases.
The in vitro release of caveolin-1 in the caveolin-1 CTS microspheres sustained for 30 days, and it was consistent with the biphasic kinetics. The initial phase was a rapid drug release phase with a burst release effect and the rate was 80.767 ± 4.801%. The latter phase was a slow drug release phase with the rate reaching 90.133 ± 3.564%, and nearly 90% released on the 30th day. The curative effect has a lagging effect compared with the release of the caveolin-1. The results of tissue staining showed that the new bone formation was found in the experimental group at the 4th and the 12th weeks. Numerous ordered collagen fibers were observed and polysaccharide expression was increased, mainly based on fibrocartilage repair. It takes time for angiogenesis and bone quality improvement, so we believe that after the release of caveolin-1, it plays an important role in improving the biomechanical properties of the bonetendon junction and promoting the formation of new bone and tendon healing. The effect at least lasted for 12 weeks after surgery.
Caveolin-1 could target Catenin, which is strategically important at adhesion junctions for its function in connecting vascular endothelialcadherin to the cytoskeleton, forming a barrier that controls fluid and solute exchange between the vascular system and interstitial tissue. (TNF)-α. 28 Therefore, we may speculate that caveolin-1 could affect bone-tendon junction healing with the involvement of the P38 MAPK pathway, which may further investigate in the future. In summary, our study supported that caveolin-1 as a slow-release material could accelerate bone-tendon junction healing, which can be well embodied in the significant increase of bone biomechanical properties and the formation of new bone and transition zone in the rabbits with bone-tendon junction injuries. With the development and population of outdoor activities and increased emergence of bone-tendon junction injuries, caveolin-1 as a slow-release material in bone-tendon junction healing is expected to be worthwhile in the treatment of bone-tendon junction injuries. As this study did not provide thorough evidence on the potential mechanism of caveolin-1 on bone-tendon junction healing, further large-scale trails are needed to confirm this conclusion.
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